Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pelvic exenteration.

H R Barber1

  • 1Department of Obstetrics and Gynecology, Lenox Hill Hospital, New York, New York 10021.

Cancer Investigation
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Pelvic exenteration, a radical surgery for recurrent pelvic cancers, is rarely performed but offers a curative option. Advances in surgical techniques and patient monitoring have significantly reduced its mortality rate to under 5%.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant disease in pregnancy.

Journal of perinatal medicine·2001
Same author

The making of a gynecologic oncologist.

European journal of gynaecological oncology·2001
Same author

Microsatellite instability in human solid tumors.

Cancer·1998
Same author

Total pelvic exenteration.

Cancer·1998
Same author

bcl-2 and p53 in endometrial adenocarcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·1997
Same author

Preoperative and postoperative care of the elderly woman.

Clinical obstetrics and gynecology·1996
Same journal

Analysis of Second Primary Tumours in Cutaneous Lymphoma Populations.

Cancer investigation·2026
Same journal

The Heterogeneity of B Cells Potentially Contributes to Metastasis of Clear Cell Renal Cell Carcinomas.

Cancer investigation·2026
Same journal

The Association Between Lymphocyte-Monocyte Ratio, Tumor-Infiltrating Lymphocytes, and Tumor-Associated Macrophages with 3-Year Progression-Free Survival in Advanced Local Stage Nasopharyngeal Cancer Patients.

Cancer investigation·2026
Same journal

<i>In Vivo</i> Pharmacokinetics, Bio-Distribution and anti-Tumor Activity of Docetaxel-Loaded Folate Targeted Biocompatible Polymeric Micelles.

Cancer investigation·2026
Same journal

Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments.

Cancer investigation·2026
Same journal

Adrenal Carcinoma Laterality is of Limited Clinical Significance: A National Perspective.

Cancer investigation·2026
See all related articles

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology

Background:

  • Pelvic exenteration is a complex surgical procedure for advanced or recurrent pelvic cancers.
  • Literature review indicates limited acceptance and reporting of exenteration, particularly outside the United States.
  • Decreasing incidence of advanced cervical cancer and challenges with ovarian cancer presentation impact exenteration indications.

Purpose of the Study:

  • To review the literature on pelvic exenteration over a 30-year period.
  • To discuss the indications, outcomes, and evolving techniques of pelvic exenteration.
  • To emphasize the importance of patient rehabilitation and quality of life post-surgery.

Main Methods:

  • Literature survey spanning 30 years.
  • Analysis of reported series, focusing on incidence, indications, and outcomes.

Related Experiment Videos

  • Review of advancements in surgical techniques and patient monitoring.

    • Main Results:

    • Exenteration is infrequently reported, with small series predominantly from the US.
    • Carcinoma of the cervix, once a primary indication, is now detected earlier.
    • Endometrial cancer is often diagnosed early; ovarian cancer presents challenges for radical pelvic surgery.
    • Pelvic exenteration remains a potentially curative option for highly selected cases of recurrent pelvic cancer.
    • Modern surgical techniques and monitoring have reduced operative blood loss, time, and mortality to below 5%.

    Conclusions:

    • Despite its rarity, pelvic exenteration offers a unique curative pathway for select patients with recurrent pelvic malignancies.
    • Improvements in surgical methods and critical care have made the procedure safer and more feasible.
    • Rehabilitation and quality of life are crucial components of post-exenteration care, enabling patients to lead fulfilling lives.